BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3918977)

  • 1. Cisplatin, a new antineoplastic drug in veterinary medicine.
    Page R; Matus RE; Leifer CE; Loar A
    J Am Vet Med Assoc; 1985 Feb; 186(3):288-90. PubMed ID: 3918977
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisplatin: a review of toxicities and therapeutic applications.
    Barabas K; Milner R; Lurie D; Adin C
    Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of nephrotoxicosis associated with a short-term saline solution diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987-1989).
    Ogilvie GK; Straw RC; Powers BE; Cooper MF; Withrow SJ
    J Am Vet Med Assoc; 1991 Sep; 199(5):613-6. PubMed ID: 1787122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of nephrotoxicosis associated with a four-hour saline solution diuresis protocol for the administration of cisplatin to dogs with naturally developing neoplasms.
    Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty M; Powers BE; Henkel SE; Withrow SJ
    J Am Vet Med Assoc; 1993 Jun; 202(11):1845-8. PubMed ID: 8320153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New frontiers in cancer chemotherapy: cis-platinum].
    Sulkes A; Peretz T; Rizel S; Yahalom Y; Brian S
    Harefuah; 1986 Jan; 110(2):90-3. PubMed ID: 3516812
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
    Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
    J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials going to the dogs: canine program to study tumor treatment, biology.
    Mack GS
    J Natl Cancer Inst; 2006 Feb; 98(3):161-2. PubMed ID: 16449674
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy discussion].
    van den Heuvel W; van der Wijden M; Spiekermann S
    Tijdschr Diergeneeskd; 2004 Jun; 129(11):382. PubMed ID: 15211910
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of butorphanol and cyproheptadine for prevention of cisplatin-induced vomiting in dogs.
    Moore AS; Rand WM; Berg J; L'Heureux DA; Dennis RA
    J Am Vet Med Assoc; 1994 Aug; 205(3):441-3. PubMed ID: 7961070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
    Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
    J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cisplatin].
    Millá A; Grau JJ; Estapé J
    Med Clin (Barc); 1983 Feb; 80(6):283-8. PubMed ID: 6345956
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer researchers usher in dog days of medicine.
    Mack GS
    Nat Med; 2005 Oct; 11(10):1018. PubMed ID: 16211022
    [No Abstract]   [Full Text] [Related]  

  • 13. [Data on toxicity and individual therapy results on anti-neoplastic antibiotics in the dog].
    Stein E
    Tierarztl Prax; 1973; 1(4):445-56. PubMed ID: 4806282
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
    Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
    Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to keep kidneys safe while shrinking tumors: the conundrum of cisplatin action.
    Goligorsky MS
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F50-1. PubMed ID: 17507601
    [No Abstract]   [Full Text] [Related]  

  • 16. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
    Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
    J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of cisplatin nephrotoxicity by probenecid.
    Daley-Yates PT; McBrien DC
    Cancer Treat Rep; 1984 Feb; 68(2):445-6. PubMed ID: 6538115
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is chemotherapy in the dog and cat ethically correct?].
    Tijdschr Diergeneeskd; 2004 Feb; 129(4):131-4. PubMed ID: 15008123
    [No Abstract]   [Full Text] [Related]  

  • 19. Cisplatin-induced nephrotoxicity.
    Meijer S; Sleijfer DT; Mulder NH; Donker AJ
    Neth J Med; 1982; 25(8):262-9. PubMed ID: 6755283
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial of benzaldehyde in pets with solid tumors: preliminary study.
    Grier RL; Merkley DF; Roth JA; Mouw MA
    Am J Vet Res; 1982 Dec; 43(12):2270-1. PubMed ID: 6762121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.